No photo of Joseph A Vetro

View Scopus Profile

Joseph A Vetro, PhD

 https://orcid.org/0000-0003-2446-9797
  • 491 Citations
  • 10 h-Index
20022020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Joseph A Vetro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Host-Directed Immunotherapy: A One Health Approach

Sanderson, S. & Vetro, J. A.

National Institutes of Health

7/7/16 → 6/30/21

Project: Research project

    • EP67-Based Targeted Mucosal Vaccines to Prevent Primary Infection with CMV

    Vetro, J. A.

    National Institutes of Health

    2/1/16 → 1/31/21

    Project: Research project

    • Development of Chol-DsiRNA Polyplexes to Improve the Therapy of Breast Cancer

    Vetro, J. A.

    National Institutes of Health

    9/15/16 → 8/31/17

    Project: Research project

    • Nebraska Center for Nanomedicine

    Vetro, J. A., Boska, M. D., Zimmerman, M. C., Poluektova, L. Y., Kabanov, A., Huanyu, D. & Batrakova, E.

    National Institutes of Health

    9/26/08 → 6/30/13

    Project: Research project

    • Development of Targeted Nanogels for siRNA Delivery to Tumor Vasculature

    Vetro, J. A.

    National Institutes of Health

    8/1/07 → 7/31/10

    Project: Research project

    • Research Output

    • 491 Citations
    • 10 h-Index
    • 16 Article
    • 2 Chapter
    • 2 Comment/debate

    Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67

    Alshammari, A. M., Smith, D. D., Parriott, J., Stewart, J. P., Curran, S. M., McCulloh, R. J., Barry, P. A., Iyer, S. S., Palermo, N., Phillips, J. A., Dong, Y., Ronning, D. R., Vennerstrom, J. L., Sanderson, S. D. & Vetro, J. A., May 8 2020, In : ACS infectious diseases. 6, 5, p. 1169-1181 13 p.

    Research output: Contribution to journal › Article

    • Surface conjugation of EP67 to biodegradable nanoparticles increases the generation of long-lived mucosal and systemic memory T-cells by encapsulated protein vaccine after respiratory immunization and subsequent T-cell-mediated protection against respiratory infection

    Tallapaka, S. B., Karuturi, B. V. K., Yeapuri, P., Curran, S. M., Sonawane, Y. A., Phillips, J. A., David Smith, D., Sanderson, S. & Vetro, J. A., Jun 30 2019, In : International journal of pharmaceutics. 565, p. 242-257 16 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Complexation of Chol-DsiRNA in place of Chol-siRNA greatly increases the duration of mRNA suppression by polyplexes of PLL(30)-PEG(5K) in primary murine syngeneic breast tumors after i.v. administration

    Ambardekar, V. V., Wakaskar, R. R., Ye, Z., Curran, S. M., McGuire, T. R., Coulter, D. W., Singh, R. K. & Vetro, J. A., May 30 2018, In : International journal of pharmaceutics. 543, 1-2, p. 130-138 9 p.

    Research output: Contribution to journal › Article

    • Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8+ T Cells in a Diameter-Dependent Manner

    Karuturi, B. V. K., Tallapaka, S. B., Yeapuri, P., Curran, S. M., Sanderson, S. D. & Vetro, J. A., May 1 2017, In : Molecular Pharmaceutics. 14, 5, p. 1469-1481 13 p.

    Research output: Contribution to journal › Article

    • 4 Scopus citations

    New generation of adjuvants for protection against disease and to combat bioterrorism

    Sanderson, S. D., Vetro, J. A. & Karuturi, B. V. K., Jan 1 2016, Neuroimmune Pharmacology. Springer International Publishing, p. 819-830 12 p.

    Research output: Chapter in Book/Report/Conference proceeding › Chapter